King Faisal Specialist Hospital and Research Centre (KFSHRC) concluded the Third Saudi Precision Oncology Summit in Madinah, held from February 12th to 14th, 2026, at King Salman International Convention Centre, bringing together leading experts from Saudi Arabia and around the world to explore the latest research and clinical developments in precision oncology and to advance best practices in cancer diagnosis and treatment.
The summit was held in the presence of Dr Majid bin Ibrahim Alfayyadh, CEO, KFSHRC and featured participation from a distinguished group of oncology specialists and researchers from Saudi Arabia and abroad.
Across the programme, scientific sessions covered a range of specialised topics, including emerging advances in cancer biology, new approaches to leukemia diagnosis and monitoring and precision oncology applications in breast and gastrointestinal cancers. They also addressed recent developments in T-cell therapies and clinical trials in precision oncology.
By encouraging scientific dialogue and knowledge exchange among specialists, the event highlighted the latest practices and real-world research in precision oncology. It also examined how molecular approaches and targeted therapies can be integrated into everyday clinical care, helping bridge research and practice and support more precise, personalized cancer diagnosis and treatment.